Fujiisawa Pharmaceutical Co., Ltd. · 66-66 · JAPAN
For Fujiisawa Pharmaceutical Co., Ltd., import alert is 66-66; country is JAPAN; import alert name is "APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"; product is Vancomycin HCl; product code is 56 K - S 85 Vancomycin Hydrochloride, Active Pharm Ingred/Chems for Further Manuf; date published is 09/30/2009; address is 3 Chome 4-7 , Dosho-Machi; Chuo , Osaka, Osaka JAPAN, verified against its source on 2026-09-30.
- Firm
- Fujiisawa Pharmaceutical Co., Ltd. verified
- Import alert
- 66-66
- Import alert name
- "APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"
- Country
- JAPAN verified
- Address
- 3 Chome 4-7 , Dosho-Machi; Chuo , Osaka, Osaka JAPAN verified
- Date published
- 09/30/2009 verified
- Product code
- 56 K - S 85 Vancomycin Hydrochloride, Active Pharm Ingred/Chems for Further Manuf verified
- Product
- Vancomycin HCl verified
- FDA notes
- 11/2/2000 verified
What the source says
Fujiisawa Pharmaceutical Co., Ltd. Date Published : 09/30/2009 3 Chome 4-7 , Dosho-Machi; Chuo , Osaka, Osaka JAPAN
— accessdata.fda.gov, retrieved 2026-09-15
Where each value comes from
The values above are stated away from the sentence quoted with the answer, so the passage that states them is shown here too.
Product code, Product and FDA notes
56 K - S 85 Vancomycin Hydrochloride, Active Pharm Ingred/Chems for Further Manuf Date Published: 03/27/2019 Desc: Vancomycin HCl Notes: 11/2/2000
— all from accessdata.fda.gov, retrieved 2026-09-15
Source
- accessdata.fda.govhttps://www.accessdata.fda.gov/cms_ia/importalert_202.html